 |
Quick Links |
| Information by Disease |
|
|
|
| Cancer News |
|
|
|
| Conference Coverage |
|
|
|
| AZN | $44.82 | -0.37 (-0.82%)
| | NVS | $53.13 | -0.16 (-0.3%)
| | SNY | $37.67 | -0.01 (-0.03%)
| | GSK | $41.53 | 0.06 (0.14%)
|
|
|
|
|
|
The purpose of Cancer News is to provide summaries of new treatment strategies as they are discovered and reported by cancer physicians around the world.
Original news summaries from peer-reviewed journals and
oncology meetings are provided daily.
 |
 News by Cancer Type |
 |
|
| We have categorized our cancer news articles by disease type.
Please select a topic from the drop down list below for more information on
that topic.
|
 |
|
|
 |
|
 |
| Latest Cancer News |
|
|
New Velcade®-melphalan Transplant Regimen for Multiple Myeloma (11/20/2009)
Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.
Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient (11/20/2009)
Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.
Prospective Study Confirms that MRI Detects More Breast Cancers in High-risk Women (11/20/2009)
Researchers from the University of Pennsylvania have reported that magnetic resonance imaging (MRI) is superior to digital mammography or ultrasound for the detection of breast cancer in high-risk women. The details of this study appeared in an early online publication in the Journal of Clinical Oncology on November 2, 2009.
Patterns of Use of Erythropoiesis-stimulating Agents in Medicare Population Reported (11/19/2009)
Researchers from Columbia Medical Center have reported that by 2002, 45.9% of Medicare recipients with common cancers were treated with erythropoiesis-stimulating agents (ESAs) such a Procrit® (epoetin alfa) and Aranesp® (darbepoietin). The details of this study appeared in an early online publication in the Journal of the National Cancer Institute on November 10, 2009.
The Incidence of Smoking-related Bladder Cancer May Be Increasing (11/19/2009)
Researchers from the National Cancer Institute and Dartmouth Medical School have reported that the risk of developing smoking-related bladder cancer has increased in New Hampshire over the risk observed in the 1990s. The details of this study appeared in the November 18, 2009 issue of the Journal of the National Cancer Institute.
Folic Acid and Vitamin B12 Increase Risk of Cancer in Patients with Heart Disease (11/19/2009)
Researchers from Norway have reported that folic acid and B12 supplements in patients with ischemic heart disease increase the risk of cancer and all-cause mortality. The details of this study appeared in the November 18, 2009 issue of the Journal of the American Medical Society.
Intravesical Taxotere® Maintenance Therapy May Improve Treatment of Superficial Bladder Cancer Refractory to BCG (11/18/2009)
Researchers from Columbia University have reported that induction and maintenance therapy with intravesical Taxotere® (docetaxel) is well tolerated and effective for treatment of patients with non-muscle-invasive bladder cancer who are refractory to Bacilli Calmette-Guerin (BCG) therapy. The details of this study were reported in the October 2009 issue of British Journal of Urology International.
Physical Activity May Reduce Risk of Developing Prostate Cancer (11/18/2009)
Researchers from U.S. and European medical centers have reported that not sitting during work, occupational activity, walking, and biking can reduce the risk of developing prostate cancer. The details of this study were published early online on October 27, 2009 in the British Journal of Cancer.
New U.S. Preventive Services Task Force Recommendations on Breast Cancer Screening (11/17/2009)
The U.S. Preventive Services Task Force (USPSTF) has released new guidelines for breast cancer screening that increase the interval between screenings for most women. The details of these new guidelines were published in the November 17, 2009 issue of the Annals of Internal Medicine and received prominent first page review in the November 17, 2009 issue of the New York Times.
Regimen of Radiotherapy, Temodar®, Avastin®, and Camptosar® Effective for Glioblastoma (11/17/2009)
Researchers from Duke University have reported that a regimen of radiotherapy (RT), Temodar® (temozolomide), and Avastin® (bevacizumab) followed by Camptosar® (irinotecan), Temodar, and Avastin after RT was well tolerated and effective for treating patients with newly diagnosed glioblastoma. The details of this Phase II study were presented at the 2009 meeting of the American Society of Radiation Therapy and Oncology (ASTRO) in the first week of November.
Elderly Patients with Bulky NHL Who Achieve a PR to Chemotherapy May Benefit from Local Radiotherapy (11/17/2009)
Researchers from Germany have reported that elderly patients with aggressive non-Hodgkin’s lymphoma (NHL) with bulky disease who achieve a partial response (PR) after chemotherapy may benefit from local radiotherapy. The details of this study were presented at the 2009 meeting of the American Society of Therapeutic Radiology and Oncology (ASTRO) in the first week of November.
Lyrica® Decreases Hot Flashes in Women with Breast Cancer (11/17/2009)
Researchers from the Mayo Clinic have reported that Lyrica® (pregabalin, [S]-3-[aminomethyl]-5-methylhexanoic acid) is effective for the treatment of hot flashes in women with breast cancer. The details of this study appeared in an early online publication on November 9, 2009 in the Journal of Clinical Oncology.
Pertuzumab plus Gemzar® Active in Platinum-resistant Ovarian Cancer (11/16/2009)
Researchers involved in an international randomized trial have reported that pertuzumab may add to the activity of Gemzar® (gemcitabine) for the treatment of platinum-resistant ovarian cancer. The details of this study appeared in an early online publication in the Journal of Clinical Oncology on November 9, 2009.
Presence of Rash Associated with Improved Survival in Patients Receiving Adjuvant Erbitux® for Locally Advanced Head and Neck Cancer (11/16/2009)
A multicenter randomized trial has shown that patients with locoregionally advanced head and neck cancer receiving adjuvant Erbitux® (cetuximab) and radiotherapy who develop a rash have a better survival than patients receiving this therapy who don’t develop a rash. The details of this five-year follow-up of a Phase III randomized study were published early online in the Lancet Oncology on November 7, 2009.
Persistent Pain Common After Breast Cancer Surgery (11/16/2009)
Researchers from Denmark have reported that pain and sensory disturbances persist for two to three years after breast cancer surgery. The details of this study were published in the November 11, 2009 issue of the Journal of the American Medical Association.
High-dose Mixed Proton and Photon Radiotherapy May Improve Treatment of Prostate Cancer (11/13/2009)
Researchers affiliated with the Proton Radiation Oncology Group (PROG)/American College of Radiology (ACR) 95-09 study have reported that mixed proton and photon radiotherapy improves outcomes of patients with low- and intermediate-risk prostate cancer. The details of this randomized trial were presented at the 2009 meeting of the American Society of Radiation Therapy and Oncology (ASTRO) in the first week of November.
Early Morning Colonoscopies Detect More Polyps (11/13/2009)
Researchers affiliated with the Veterans Administration of greater Los Angeles have reported that a greater number of polyps was detected among patients seen early in the morning than among patients seen later in the day. The reasons for this are uncertain, but it’s possible that the lower rate of polyp detection later in the day is the result of provider fatigue or less complete bowel preparation. These results were published in November, 2009 issue of Clinical Gastroenterology and Hepatology.
Primary Care Physicians May Be Ordering More Pap Smears Than Necessary (11/13/2009)
Researchers from the National Institutes of Health have reported that primary care physicians overuse Pap smear testing and are not following current recommendations. The details of this study appeared in the November 3, 2009 issue of the Annals of Internal Medicine.
Excess Body Weight Linked with More Than 100,000 New Cancer Diagnoses Each Year in U.S. (11/12/2009)
According to estimates from the American Institute for Cancer Research (AICR), excess body weight may be responsible for more than 100,000 new cancer diagnoses each year in the United States.
Israeli Jewish Holocaust Survivors May Have Increased Risk of Cancer (11/12/2009)
Researchers from Israel have reported that the incidence of all cancers, and especially breast and colorectal cancers, is higher among Israeli Jews who were potentially exposed to the Holocaust compared with those who were not. The details of this study were published in the November 4, 2009 issue of the Journal of the National Cancer Institute.
More Clinical News »
|
|
|
|
 Member Center |
|
|
 |
Register in our member center today to receive email notification of late breaking cancer news.
Learn More »
|
|
|
|
|
|
|
 Practice Resources |
|
|
 |
Learn how to receive our news headlines on your website.
Learn More »
|
|
|
|
|
|
|
 Links to Information by Cancer Type |
|
|
|
|
|
|
|
|
|
Patient Home
